| JaLCDOI |
10.18926/AMO/54512
|
| FullText URL |
70_4_317.pdf
|
| Author |
Sakurai, Jun|
Matsui, Yusuke|
Hiraki, Takao|
Iguchi, Toshihiro|
Fujiwara, Hiroyasu|
Gobara, Hideo|
Mitsuhashi, Toshiharu|
Nagasaka, Takeshi|
Susumu Kanazawa, Susumu Kanazawa|
|
| Abstract |
The present single center prospective phase II clinical trial is designed to evaluate the efficacy and safety of percutaneous radiofrequency (RF) ablation for colorectal lung metastases. Patients who have colorectal lung metastases without extrapulmonary metastases are included in this study. The primary endpoint is 3-year overall survival (OS) after RF ablation. The secondary endpoints are the prevalence of adverse events within 4 weeks, local tumor progression rate, 1- and 5-year OS, cause-specific survival, and relapse-free survival. The recruitment of patients commenced in July 2014, and the enrolment of 45 patients is intended over the 3 years of study period.
|
| Keywords |
radiofrequency ablation
colorectal cancer
lung metastasis
|
| Amo Type |
Clinical Study Protocols
|
| Publication Title |
Acta Medica Okayama
|
| Published Date |
2016-08
|
| Volume |
volume70
|
| Issue |
issue4
|
| Publisher |
Okayama University Medical School
|
| Start Page |
317
|
| End Page |
321
|
| ISSN |
0386-300X
|
| NCID |
AA00508441
|
| Content Type |
Journal Article
|
| language |
English
|
| Copyright Holders |
CopyrightⒸ 2016 by Okayama University Medical School
|
| File Version |
publisher
|
| Refereed |
True
|
| PubMed ID |
27549681
|
| Web of Science KeyUT |
000384748600016
|
